Organ specific responses to first-line lenvatinib plus anti-PD-1 antibodies in patients with unresectable hepatocellular carcinoma: a retrospective analysis

by Cheng Huang, Xiao-Dong Zhu, Ying-Hao Shen, Dong Wu, Yuan Ji, Ning-Ling Ge, Ling-Li Chen, Chang-Jun Tan, Jian Zhou, Jia Fan, Hui-Chuan Sun
Published 2021-03-01

Activation of PI3K/AKT and MAPK pathway through a PDGFRβ-dependent feedback loop is involved in rapamycin resistance in hepatocellular carcinoma.

by Quan-Lin Li, Fang-Ming Gu, Zheng Wang, Jia-Hao Jiang, Li-Qing Yao, Chang-Jun Tan, Xiao-Yong Huang, Ai-Wu Ke, Zhi Dai, Jia Fan, Jian Zhou
Published 2012-01-01

Downstaging and Resection of Initially Unresectable Hepatocellular Carcinoma with Tyrosine Kinase Inhibitor and Anti-PD-1 Antibody Combinations

by Xiao-Dong Zhu, Cheng Huang, Ying-Hao Shen, Yuan Ji, Ning-Ling Ge, Xu-Dong Qu, Lingli Chen, Wen-Kai Shi, Mei-Ling Li, Jin-Jin Zhu, Chang-Jun Tan, Zhao-You Tang, Jian Zhou, Jia Fan, Hui-Chuan Sun
Published 2021-03-01